Objectives: To conduct an in vitro evaluation of a humidified high-flow nasal cannula (HFNC) system at different flows, cannula sizes, and air leaks and also an in vivo analysis of mean end-expiratory esophageal pressure (EEEP) from nasal continuous positive airway pressure at 6 cm H(2)O (NCPAP+6) versus HFNC.
Study Design: In the in vitro study, we measured HFNC system pressure and flow, with varying degrees of leak and with and without the use of a pressure-limiting valve. In the in vivo study, we measured EEEP in 15 newborns on NCPAP+6 and then on HFNC at 6 L/minute, with flow decreased by 1 L/minute every 30 minutes. Heart rate, respiratory rate, fraction of inspired oxygen, arterial oxygen saturation, respiratory distress syndrome score, and EEEP were recorded for each intervention. Data analysis was done using repeated-measures analysis of variance and linear regression.
Results: In the in vitro study, in the absence of leaks, the pressures were limited by the pressure-limiting valve only at flows > or = 2 L/minute. With leaks of 30% and 50%, delivered pressures were always < 3 cm H(2)O. In the in vivo study, respiratory rate increased from baseline (NCPAP+6) as flow decreased (P < .02). Intrapatient and interpatient coefficients of variation were always high.
Conclusions: A pressure-limiting valve is necessary in a HFNC system. Although mean EEEP levels were similar in NCPAP+6 and HFNC, tachypnea developed as flow diminished. This system apparently cannot predict EEEP, because of interpatient and intrapatient variation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpeds.2008.07.021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Wellcome Open Res
December 2024
Oxford University Clinical Research Unit, Ho Chi Minh City, Ho Chi Minh, Vietnam.
Background: Awake prone positioning (APP) may be beneficial in patients with respiratory failure who are not receiving mechanical ventilation. Randomized controlled trials of APP have been performed during peak COVID-19 periods in unvaccinated populations, with limited data on compliance or patient acceptability. We aimed to evaluate the efficacy and acceptability of APP in a lower-middle income country in an open-label randomized controlled trial using a dedicated APP implementation team and wearable continuous-monitoring devices.
View Article and Find Full Text PDFHigh flow nasal cannula and low level continuous positive airway pressure have different physiological effects during de novo acute hypoxemic respiratory failure.
Ann Intensive Care
November 2024
Groupe de Recherche Clinique CARMAS, Faculté de Santé, Université Paris Est-Créteil, Créteil Cedex, 94010, France.
Background: Large tidal volumes during de novo acute hypoxemic respiratory failure (AHRF) may promote patient self-inflicted lung injury. Tidal volume assessment under high flow nasal cannula (HFNC) is not routinely feasible at the bedside. Our objective was to determine whether tidal volume during low-level continuous positive airway pressure (CPAP) could predict tidal volume during HFNC and to compare the physiological effects of HFNC and low-level CPAP.
View Article and Find Full Text PDFRisk factors affecting the development of pneumothorax in patients followed up in intensive care with a diagnosis of COVID-19.
BMC Infect Dis
November 2024
Department of Critical Care, Marmara University Pendik Training and Research Hospital, Pendik, Istanbul, Turkey.
Article Synopsis
- Pneumothorax is a rare but serious complication of COVID-19 that leads to worse patient outcomes, requiring more respiratory support, longer hospital stays, and increased mortality.
- This observational study reviewed 100 patients in the COVID-19 ICU who underwent tube thoracostomy due to pneumothorax, analyzing their demographics and clinical data.
- Findings indicated that the majority of patients were older males (median age 68), with high rates of intubation and significant respiratory support needed, highlighting critical factors that could predict mortality in these cases.
Impact of High-Flow Nasal Cannula Oxygen Therapy on the Pressure of the Airway System in Humans.
Respir Care
October 2024
Mrs Moracci and Plotnikow are affiliated with the Physical and Respiratory Therapy Department, Intensive Care Unit, Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Background: The understanding of how pharyngeal pressure is transmitted to the trachea with high-flow nasal cannula (HFNC) implementation and the behavior of tracheal pressure in the presence of mouth leaks remains limited. This study aimed to assess the impact of HFNC administration on tracheal pressure by comparing measurements taken with open and closed mouth with varying flows.
Methods: A crossover study was conducted between March 2019 and June 2023.
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study.
Crit Care
October 2024
Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Background: The benefit of Inhaled nitric oxide (iNO) therapy in the setting of COVID-19-related ARDS is obscure. We performed a multicenter retrospective study to evaluate the impact of iNO on patients with COVID-19 who require respiratory support.
Methods: This retrospective multicenter study included COVID-19 patients enrolled in the SCCM VIRUS COVID-19 registry who were admitted to different Mayo Clinic sites between March 2020 and June 2022 and required high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), or invasive mechanical ventilation (IMV).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!